Hospitalization Trends for Airway Infections and In-Hospital Complications in Cleft Lip and Palate.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
03 Sep 2024
Historique:
medline: 12 9 2024
pubmed: 12 9 2024
entrez: 12 9 2024
Statut: epublish

Résumé

Cleft lip or palate is a prevalent birth defect, occurring in approximately 1 to 2 per 1000 newborns and often necessitating numerous hospitalizations. Specific rates of hospitalization and complication are underexplored. To assess the rates of airway infection-associated hospitalization, overall hospital admissions, in-hospital complications, and mortality among children with a cleft lip or palate. This nationwide, population-based cohort study used in-hospital claims data from the Federal Statistical Office in Switzerland between 2012 and 2021. Participants included newborns with complete birth records born in a Swiss hospital. Data were analyzed from March to November 2023. Prevalent diagnosis of a cleft lip or palate at birth. Outcomes of interest were monthly hospitalization rates for airway infections and any cause during the first 2 years of life in newborns with cleft lip or palate. In-hospital outcomes and mortality outcomes were also assessed, stratified by age and modality of surgical intervention. Of 857 806 newborns included, 1197 (0.1%) had a cleft lip and/or palate, including 170 (14.2%) with a cleft lip only, 493 (41.2%) with a cleft palate only, and 534 (44.6%) with cleft lip and palate. Newborns with cleft lip or palate were more likely to be male (55.8% vs 51.4%), with lower birth weight (mean [SD] weight, 3135.6 [650.8] g vs 3284.7 [560.7] g) and height (mean [SD] height, 48.6 [3.8] cm vs 49.3 [3.2] cm). During the 2-year follow-up, children with a cleft lip or palate showed higher incidence rate ratios (IRRs) for hospitalizations due to airway infections (IRR, 2.33 [95% CI, 1.98-2.73]) and for any reason (IRR, 3.72 [95% CI, 3.49-3.97]) compared with controls. Additionally, children with cleft lip or palate had a substantial increase in odds of mortality (odds ratio [OR], 17.97 [95% CI, 11.84-27.29]) and various complications, including the need for intubation (OR, 2.37 [95% CI, 1.95-2.87]), extracorporeal membrane oxygenation (OR, 2.89 [95% CI, 1.81-4.63]), cardiopulmonary resuscitation (OR, 3.25 [95% CI, 2.21-4.78]), and respiratory support (OR, 1.94 [95% CI, 1.64-2.29]). In this nationwide cohort study, the presence of cleft lip or palate was associated with increased hospitalization rates for respiratory infections and other causes, as well as poorer in-hospital outcomes and greater resource use.

Identifiants

pubmed: 39264632
pii: 2823639
doi: 10.1001/jamanetworkopen.2024.28077
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2428077

Auteurs

Rahel Laager (R)

Department of Internal Medicine, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland.
University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
Faculty of Medicine, University of Basel, Basel, Switzerland.

Claudia Gregoriano (C)

Department of Internal Medicine, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland.

Stephanie Hauser (S)

Department of Internal Medicine, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland.
Department of Pediatrics, Kantonsspital Graubünden, Chur, Switzerland.

Henrik Koehler (H)

Faculty of Medicine, University of Basel, Basel, Switzerland.
Department of Pediatrics, Kantonsspital Aarau, Aarau, Switzerland.

Philipp Schuetz (P)

Department of Internal Medicine, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland.
Faculty of Medicine, University of Basel, Basel, Switzerland.
Department of Endocrinology and Diabetology, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland.

Beat Mueller (B)

Faculty of Medicine, University of Basel, Basel, Switzerland.
Department of Endocrinology and Diabetology, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland.

Alexander Kutz (A)

Department of Internal Medicine, Medical University Clinic, Kantonsspital Aarau, Aarau, Switzerland.
Faculty of Medicine, University of Basel, Basel, Switzerland.
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH